Her Excellency Madame Fu Ying, Ambassador of the People’s Republic of China, today officially opened ‘Meditrina’, the newest Bioincubator building at the Babraham Research Campus, and welcomed the first Chinese company to the campus, near Cambridge.
Traditional Chinese Medicine company is the 50th company to join the Babraham Bioincubator...
The XiangCam TCM Research Centre (XiangCam) is a pioneering collaboration between Chinese enterprise and academic institutions in
Dr David Hardman, CEO of Babraham Biosciences Technologies (BBT) said, “We are delighted that Guangzhou Xiangxue Pharmaceuticals (Xiangxue) chose Babraham as its first overseas research base for XiangCam. Not only is Xiangxue the first overseas bioventure in our facilities, it is also the 50th biomedical company to locate to the Babraham Research Campus since the Bioincubator opened in 1999.”
This is the first time that Chinese Pharma has invested in a Traditional Chinese Medicine research organisation in the
“Traditional Chinese Medicine is very popular in
Sir Robin Young, Chairman of East of England International said, ”This is a great model of Anglo-Chinese and inter-university collaboration and we are fortunate to have its hub located in the Babraham Incubator, which is itself an attraction in its own right to attract knowledge in the life science sector. In future cross-border collaboration between universities and businesses to reduce development lead times and costs and secure competitive advantage will become increasingly important. On behalf of EEI, I would like to wish all collaborators every success with their research.”
“There are many other examples of successful pharmaceutical compounds which owe their origins to the natural world and to folk medicine, and it seems likely that there are many more waiting to be discovered. One major interest of this collaboration will be to understand how different components of several herbs can promote or inhibit the growth of new blood vessels, a process called angiogenesis. This knowledge may be useful in developing novel anti-cancer agents, because preventing the formation of new blood vessels provides a powerful means of inhibiting tumour growth."
“Dr Tai-Ping Fan, senior lecturer in the Department of Pharmacology at
Other UK partners include the Royal Botanic Gardens, Kew, which will authenticate a selection of TCM herbs prior to chemical, pharmaceutical and toxicological analysis by teams at Brunel University, Bradford University, the London School of Pharmacy, Guy’s & St Thomas’ Hospital. In addition to elucidating the cellular and molecular mechanisms behind the actions of single TCM herbs, or formulas including several different herbs, a further outcome will be a reference library for TCM standards. “Leads” identified through the Anglo-Chinese collaborative research projects will then undergo clinical research in
Meditrina, named after the Roman goddess of medicine, was part-funded by a capital grant of £2 million from the East of England Development Agency (EEDA) in partnership with the Biotechnology and Biological Sciences Research Council (BBSRC) enabling the construction of this state-of-the-art £7million Bioincubator.
Babraham Bioscience Technologies Ltd is the wholly-owned subsidiary and trading arm of the Babraham Institute. Coalescing scientific, technological and commercial excellence, BBT delivers the Knowledge Transfer remit of the Institute through the wider landscape of the Babraham Research Campus, catalysing opportunities for enterprise across the academic and commercial divide. BBT brings together all the elements to support innovation and enable the successful exploitation of research in the biomedical sector based on technologies emanating from the Babraham Institute and bioventures relocating to the Babraham Research Campus.
The Babraham Research Campus is the UK’s leading knowledge-driven Biomedical Park where world-class research, business know-how and entrepreneurial excellence come together to stimulate effective knowledge transfer and bridge the academic and commercial divide. The campus provides a unique and highly successful environment that actively fosters innovation and plays a pivotal role for biomedical start-up companies in the
The Babraham Institute is an independent charitable organisation, sponsored by the Biotechnology and Biological Sciences Research Council, carrying out world-leading innovative research and advanced training with relevance to the biomedical, biotechnological, pharmaceutical and healthcare research and user communities. The Institute’s research focuses on the mechanisms of cell signalling and gene regulation, which underlie normal cellular processes and functions, and on how their failure or abnormality may lead to disease. As such, Institute scientists are striving to find cures for conditions where there is currently no treatment or where the existing treatment is not fully effective or causes serious side effects. The latest technologies are being used to study the basis of conditions such as neurodegenerative disorders, foetal abnormality, cancer and diseases of the immune and cardiovascular systems. The commercialisation of the Institute’s research is managed by its trading subsidiary, Babraham Bioscience Technologies Ltd. The Babraham Research Campus is located six miles south-east of
Guangzhou Xiangxue Pharmaceuticals Co. (Xiangxue) is based in
East of England International (EEI) is the official regional organisation that provides business support to companies seeking to trade internationally and assists foreign-owned businesses looking to invest in the region. EEI is funded by and works in partnership with the UK Government, the East of England Development Agency (EEDA) and a wide range of businesses and partners in the region. East of England International (EEI), the region¹s international business support organisation, worked closely with Xiangxue Pharmaceuticals as it selected and then prepared to open its
UK Trade & Investment is the government organisation that provides integrated support services for
East of England Development Agency (EEDA) is the driving force behind sustainable economic regeneration in the East of England: Bedfordshire, Cambridgeshire, Essex, Hertfordshire,
Photos will be available on request
Babraham Bioscience Technologies Ltd Fax: +44 (0)1223 496020
Babraham Institute Fax: +44 (0)1223 496002
The Institute is an independent charitable life sciences research institute, strategically funded by the Biotechnology and Biological Sciences Research Council.